India's first child using PGT-M, PGT-A and HLA matching for helping a sibling having β-thalassemia major

0Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

β-thalassemia is a common single-gene disorder in India, with hematopoietic stem cell transplantation (HSCT) being the only cure. HSCT with matched unrelated donor is less successful, whereas finding a human leukocyte antigen (HLA)-matched related donor is difficult. Preimplantation genetic testing for monogenic diseases (PGT-M) with HLA matching is a novel option to have a matched sibling for HSCT for couples having an affected child. We present the first such case report in India. A couple, both carriers of β-thalassemia and having an affected son, underwent PGT-M with HLA matching combined with preimplantation genetic testing for aneuploidies of embryos to have a β - thalassemia-free child. This resulted in birth of a 10/10 HLA-matched sibling.

Cite

CITATION STYLE

APA

Banker, J., Arora, P., Khajuria, R., & Banker, M. (2019). India’s first child using PGT-M, PGT-A and HLA matching for helping a sibling having β-thalassemia major. Journal of Human Reproductive Sciences, 12(4), 341–344. https://doi.org/10.4103/jhrs.JHRS_50_19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free